Determination of the antibacterial activity of atorvastatin against periodontal pathogens, Aggregatibacter actinomycetemcomitans and Porphyromonas gingivalis: An in vitro study
Aim: The aim of the present study was to determine the antimicrobial activity of pure atorvastatin drug against the primary periodontal pathogens. Materials and Methods: Both minimum inhibitory concentrations and minimum bactericidal concentrations were used to assess the antibacterial effect of ato...
Gespeichert in:
Veröffentlicht in: | Journal of Interdisciplinary Dentistry 2020, Vol.10 (1), p.3-8 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 8 |
---|---|
container_issue | 1 |
container_start_page | 3 |
container_title | Journal of Interdisciplinary Dentistry |
container_volume | 10 |
creator | Das, Swetalin Pudakalkatti, PushpaS Vaz, Ancia Kour, Prabhdeep Padmanabhan, Sreeshma |
description | Aim: The aim of the present study was to determine the antimicrobial activity of pure atorvastatin drug against the primary periodontal pathogens. Materials and Methods: Both minimum inhibitory concentrations and minimum bactericidal concentrations were used to assess the antibacterial effect of atorvastatin against Actinobaillus actinomycetemcomitans and Prophyromonas gingivalis by serial dilution method and culture method, respectively. Results: In the present study, both A. actinomycetemcomitans and P. gingivalis were sensitive to pure atorvastatin drug. P. gingivalis was found to be more sensitive than A. actinomycetemcomitans in this study. Conclusions: Data suggest a potent antimicrobial activity of atorvastatin against both A. actinomycetemcomitans and P. gingivalis. Hence, atorvastatin can be prescribed as a dual action drug in patients suffering from both hyperlipidemia and periodontal disease. |
doi_str_mv | 10.4103/jid.jid_33_19 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2401599979</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2401599979</sourcerecordid><originalsourceid>FETCH-LOGICAL-c136t-152e01d97aaf398e39291934031014a8d4fd051bb71b7c32cfcd4adacdfe4b433</originalsourceid><addsrcrecordid>eNo9kctqwzAQRUVpoSHNsntBt3UqWXIcdRfSJwTaRbs2Y0l2FGLJlZSA_6qfWLkvwaCBOdyzuAhdUjLnlLCbnVHzNBVjFRUnaJLnjGZ5SRan456LrKCCn6NZCDuS3mLJRckn6PNOR-07YyEaZ7FrcNxqDDaaGmS6GNjjtJijicN4hej8EUJMuMXQgrEh4j5xTjkbE9xD3LpW23CNV23rdQt_Ud851nWDTMpOus5EsCG5FH51vt8O3nXOQsCtsa05wt6EW7yyOImS3Tsc4kENF-isgX3Qs99_it4f7t_WT9nm5fF5vdpkkrJFzGiRa0KVKAEaJpaaiVxQwThhlFAOS8UbRQpa1yWtS8ly2UjFQYFUjeY1Z2yKrn5ye-8-DjrEaucO3iZllXNCCyFEKRKV_VDSuxC8bqremw78UFFSjb1UYyf_vbAvWp-IaQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2401599979</pqid></control><display><type>article</type><title>Determination of the antibacterial activity of atorvastatin against periodontal pathogens, Aggregatibacter actinomycetemcomitans and Porphyromonas gingivalis: An in vitro study</title><source>Medknow Open Access Medical Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Das, Swetalin ; Pudakalkatti, PushpaS ; Vaz, Ancia ; Kour, Prabhdeep ; Padmanabhan, Sreeshma</creator><creatorcontrib>Das, Swetalin ; Pudakalkatti, PushpaS ; Vaz, Ancia ; Kour, Prabhdeep ; Padmanabhan, Sreeshma</creatorcontrib><description>Aim: The aim of the present study was to determine the antimicrobial activity of pure atorvastatin drug against the primary periodontal pathogens. Materials and Methods: Both minimum inhibitory concentrations and minimum bactericidal concentrations were used to assess the antibacterial effect of atorvastatin against Actinobaillus actinomycetemcomitans and Prophyromonas gingivalis by serial dilution method and culture method, respectively. Results: In the present study, both A. actinomycetemcomitans and P. gingivalis were sensitive to pure atorvastatin drug. P. gingivalis was found to be more sensitive than A. actinomycetemcomitans in this study. Conclusions: Data suggest a potent antimicrobial activity of atorvastatin against both A. actinomycetemcomitans and P. gingivalis. Hence, atorvastatin can be prescribed as a dual action drug in patients suffering from both hyperlipidemia and periodontal disease.</description><identifier>ISSN: 2229-5194</identifier><identifier>EISSN: 2231-2706</identifier><identifier>DOI: 10.4103/jid.jid_33_19</identifier><language>eng</language><publisher>Mumbai: Medknow Publications & Media Pvt. Ltd</publisher><subject>Antibacterial activity ; Antibiotics ; Antimicrobial activity ; Antimicrobial agents ; Atorvastatin ; Bacteria ; Chemical synthesis ; Cholesterol ; Drug dosages ; Hyperlipidemia ; Molecular structure ; Organisms ; Pathogens ; Periodontal diseases ; Proteins ; Statins ; Studies</subject><ispartof>Journal of Interdisciplinary Dentistry, 2020, Vol.10 (1), p.3-8</ispartof><rights>2020. This article is published under (http://creativecommons.org/licenses/by-nc-sa/3.0/) (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c136t-152e01d97aaf398e39291934031014a8d4fd051bb71b7c32cfcd4adacdfe4b433</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Das, Swetalin</creatorcontrib><creatorcontrib>Pudakalkatti, PushpaS</creatorcontrib><creatorcontrib>Vaz, Ancia</creatorcontrib><creatorcontrib>Kour, Prabhdeep</creatorcontrib><creatorcontrib>Padmanabhan, Sreeshma</creatorcontrib><title>Determination of the antibacterial activity of atorvastatin against periodontal pathogens, Aggregatibacter actinomycetemcomitans and Porphyromonas gingivalis: An in vitro study</title><title>Journal of Interdisciplinary Dentistry</title><description>Aim: The aim of the present study was to determine the antimicrobial activity of pure atorvastatin drug against the primary periodontal pathogens. Materials and Methods: Both minimum inhibitory concentrations and minimum bactericidal concentrations were used to assess the antibacterial effect of atorvastatin against Actinobaillus actinomycetemcomitans and Prophyromonas gingivalis by serial dilution method and culture method, respectively. Results: In the present study, both A. actinomycetemcomitans and P. gingivalis were sensitive to pure atorvastatin drug. P. gingivalis was found to be more sensitive than A. actinomycetemcomitans in this study. Conclusions: Data suggest a potent antimicrobial activity of atorvastatin against both A. actinomycetemcomitans and P. gingivalis. Hence, atorvastatin can be prescribed as a dual action drug in patients suffering from both hyperlipidemia and periodontal disease.</description><subject>Antibacterial activity</subject><subject>Antibiotics</subject><subject>Antimicrobial activity</subject><subject>Antimicrobial agents</subject><subject>Atorvastatin</subject><subject>Bacteria</subject><subject>Chemical synthesis</subject><subject>Cholesterol</subject><subject>Drug dosages</subject><subject>Hyperlipidemia</subject><subject>Molecular structure</subject><subject>Organisms</subject><subject>Pathogens</subject><subject>Periodontal diseases</subject><subject>Proteins</subject><subject>Statins</subject><subject>Studies</subject><issn>2229-5194</issn><issn>2231-2706</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNo9kctqwzAQRUVpoSHNsntBt3UqWXIcdRfSJwTaRbs2Y0l2FGLJlZSA_6qfWLkvwaCBOdyzuAhdUjLnlLCbnVHzNBVjFRUnaJLnjGZ5SRan456LrKCCn6NZCDuS3mLJRckn6PNOR-07YyEaZ7FrcNxqDDaaGmS6GNjjtJijicN4hej8EUJMuMXQgrEh4j5xTjkbE9xD3LpW23CNV23rdQt_Ud851nWDTMpOus5EsCG5FH51vt8O3nXOQsCtsa05wt6EW7yyOImS3Tsc4kENF-isgX3Qs99_it4f7t_WT9nm5fF5vdpkkrJFzGiRa0KVKAEaJpaaiVxQwThhlFAOS8UbRQpa1yWtS8ly2UjFQYFUjeY1Z2yKrn5ye-8-DjrEaucO3iZllXNCCyFEKRKV_VDSuxC8bqremw78UFFSjb1UYyf_vbAvWp-IaQ</recordid><startdate>2020</startdate><enddate>2020</enddate><creator>Das, Swetalin</creator><creator>Pudakalkatti, PushpaS</creator><creator>Vaz, Ancia</creator><creator>Kour, Prabhdeep</creator><creator>Padmanabhan, Sreeshma</creator><general>Medknow Publications & Media Pvt. Ltd</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>2020</creationdate><title>Determination of the antibacterial activity of atorvastatin against periodontal pathogens, Aggregatibacter actinomycetemcomitans and Porphyromonas gingivalis: An in vitro study</title><author>Das, Swetalin ; Pudakalkatti, PushpaS ; Vaz, Ancia ; Kour, Prabhdeep ; Padmanabhan, Sreeshma</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c136t-152e01d97aaf398e39291934031014a8d4fd051bb71b7c32cfcd4adacdfe4b433</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Antibacterial activity</topic><topic>Antibiotics</topic><topic>Antimicrobial activity</topic><topic>Antimicrobial agents</topic><topic>Atorvastatin</topic><topic>Bacteria</topic><topic>Chemical synthesis</topic><topic>Cholesterol</topic><topic>Drug dosages</topic><topic>Hyperlipidemia</topic><topic>Molecular structure</topic><topic>Organisms</topic><topic>Pathogens</topic><topic>Periodontal diseases</topic><topic>Proteins</topic><topic>Statins</topic><topic>Studies</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Das, Swetalin</creatorcontrib><creatorcontrib>Pudakalkatti, PushpaS</creatorcontrib><creatorcontrib>Vaz, Ancia</creatorcontrib><creatorcontrib>Kour, Prabhdeep</creatorcontrib><creatorcontrib>Padmanabhan, Sreeshma</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Biological Science Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Journal of Interdisciplinary Dentistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Das, Swetalin</au><au>Pudakalkatti, PushpaS</au><au>Vaz, Ancia</au><au>Kour, Prabhdeep</au><au>Padmanabhan, Sreeshma</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Determination of the antibacterial activity of atorvastatin against periodontal pathogens, Aggregatibacter actinomycetemcomitans and Porphyromonas gingivalis: An in vitro study</atitle><jtitle>Journal of Interdisciplinary Dentistry</jtitle><date>2020</date><risdate>2020</risdate><volume>10</volume><issue>1</issue><spage>3</spage><epage>8</epage><pages>3-8</pages><issn>2229-5194</issn><eissn>2231-2706</eissn><abstract>Aim: The aim of the present study was to determine the antimicrobial activity of pure atorvastatin drug against the primary periodontal pathogens. Materials and Methods: Both minimum inhibitory concentrations and minimum bactericidal concentrations were used to assess the antibacterial effect of atorvastatin against Actinobaillus actinomycetemcomitans and Prophyromonas gingivalis by serial dilution method and culture method, respectively. Results: In the present study, both A. actinomycetemcomitans and P. gingivalis were sensitive to pure atorvastatin drug. P. gingivalis was found to be more sensitive than A. actinomycetemcomitans in this study. Conclusions: Data suggest a potent antimicrobial activity of atorvastatin against both A. actinomycetemcomitans and P. gingivalis. Hence, atorvastatin can be prescribed as a dual action drug in patients suffering from both hyperlipidemia and periodontal disease.</abstract><cop>Mumbai</cop><pub>Medknow Publications & Media Pvt. Ltd</pub><doi>10.4103/jid.jid_33_19</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2229-5194 |
ispartof | Journal of Interdisciplinary Dentistry, 2020, Vol.10 (1), p.3-8 |
issn | 2229-5194 2231-2706 |
language | eng |
recordid | cdi_proquest_journals_2401599979 |
source | Medknow Open Access Medical Journals; EZB-FREE-00999 freely available EZB journals |
subjects | Antibacterial activity Antibiotics Antimicrobial activity Antimicrobial agents Atorvastatin Bacteria Chemical synthesis Cholesterol Drug dosages Hyperlipidemia Molecular structure Organisms Pathogens Periodontal diseases Proteins Statins Studies |
title | Determination of the antibacterial activity of atorvastatin against periodontal pathogens, Aggregatibacter actinomycetemcomitans and Porphyromonas gingivalis: An in vitro study |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T14%3A02%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Determination%20of%20the%20antibacterial%20activity%20of%20atorvastatin%20against%20periodontal%20pathogens,%20Aggregatibacter%20actinomycetemcomitans%20and%20Porphyromonas%20gingivalis:%20An%20in%20vitro%20study&rft.jtitle=Journal%20of%20Interdisciplinary%20Dentistry&rft.au=Das,%20Swetalin&rft.date=2020&rft.volume=10&rft.issue=1&rft.spage=3&rft.epage=8&rft.pages=3-8&rft.issn=2229-5194&rft.eissn=2231-2706&rft_id=info:doi/10.4103/jid.jid_33_19&rft_dat=%3Cproquest_cross%3E2401599979%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2401599979&rft_id=info:pmid/&rfr_iscdi=true |